BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aita A, Millino C, Sperti C, Pacchioni B, Plebani M, Pittà C, Basso D. Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study. Biomedicines 2021;9:845. [PMID: 34356909 DOI: 10.3390/biomedicines9070845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 McGowan R, Sally Á, McCabe A, Moran BM, Finn K. Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2022;14:2027. [PMID: 35454933 DOI: 10.3390/cancers14082027] [Reference Citation Analysis]
2 Roalsø MTT, Hald ØH, Alexeeva M, Søreide K. Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma. Cancers 2022;14:546. [DOI: 10.3390/cancers14030546] [Reference Citation Analysis]
3 Lovat F. Editorial to the Special Issue "MicroRNA in Solid Tumor and Hematological Diseases". Biomedicines 2021;9:1678. [PMID: 34829905 DOI: 10.3390/biomedicines9111678] [Reference Citation Analysis]